MGMT and glioblastoma: The effectiveness of this strategy in opening the BBB for the delivery of the liposome-loaded O6-Methylguanine-DNA methyltransferase (MGMT) inactivator, in combination with TMZ treatment, has been established to decrease the growth of GBM and increase the survival of mice bearing TMZ-resistant tumors [75].